Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic enteral lactoferrin to prevent late-onset invasive infection in very preterm infants
2012-004260-22Phase 3Completed
- Sponsor
- University of Oxford
- Start
- Sep 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial in invasive infection, bacterial disease and mycoses comparing Bovine lactoferrin with Placebo (2 arms). Primary endpoint: Incidence of late-onset invasive infection. Started Sep 2013; status: completed.
02
Drugs
lactoferrin
03
Conditions
invasive infectionbacterial diseasemycoses
Beyond the preview
Go deeper on 2012-004260-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-004260-22.